Trestle Biotherapeutics
Harvard Bioprinting Tech Licensed to Ex-Organovo Execs for Bioprinted Kidneys
San Diego-based Trestle Biotherapeutics has initiated an agreement with Harvard University to license the school’s stem cell and bioprinting technology. The goal is to 3D print kidney tissue for regenerative…